patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · small molecule
daridorexant hydrochloride
Marketedupdated 2mo agoby Idorsia Pharmaceutical Ltd🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval, with an approval for insomnia.
targets
Orexin receptor type 2Orexin/Hypocretin receptor type 1
all catalysts(1)
phase 2 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that